These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 763147)

  • 1. The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis.
    Ferrannini E; Pilo A; Tuoni M
    Metabolism; 1979 Feb; 28(2):125-36. PubMed ID: 763147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
    Shasha SM; Nusem D; Kanter Y; Weiner F
    Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects.
    Schmitz O
    Diabetes; 1985 Nov; 34(11):1152-9. PubMed ID: 3899812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dialysis treatment on glucose metabolism in uremic patients.
    Kaneda H; Mimura N
    Tohoku J Exp Med; 1977 May; 122(1):35-42. PubMed ID: 918954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four methods for glucose assay compared for various glucose concentrations and under different clinical conditions.
    Giampietro O; Pilo A; Buzzigoli G; Boni C; Navalesi R
    Clin Chem; 1982 Dec; 28(12):2405-7. PubMed ID: 7139920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.
    DeFronzo RA; Tobin JD; Rowe JW; Andres R
    J Clin Invest; 1978 Aug; 62(2):425-35. PubMed ID: 353075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia.
    Davidson MB; Fisher MB; Dabir-Vaziri N; Schaffer M
    Metabolism; 1976 Apr; 25(4):455-64. PubMed ID: 1263839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous calcitriol normalizes insulin sensitivity in uremic patients.
    Kautzky-Willer A; Pacini G; Barnas U; Ludvik B; Streli C; Graf H; Prager R
    Kidney Int; 1995 Jan; 47(1):200-6. PubMed ID: 7731147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads.
    Allegra V; Mengozzi G; Martimbianco L; Vasile A
    Kidney Int; 1990 Dec; 38(6):1146-50. PubMed ID: 1963648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of growth hormone in the glucose intolerance of uremia.
    DeFronzo RA; Tobin J; Boden G; Andres R
    Acta Diabetol Lat; 1979; 16(4):279-86. PubMed ID: 399149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin, branched-chain amino acids, and growth failure in uremia.
    Mak RH
    Pediatr Nephrol; 1998 Oct; 12(8):637-42. PubMed ID: 9811385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique.
    Schmitz O; Alberti KG; Christensen NJ; Hasling C; Hjøllund E; Beck-Nielsen H; Orskov H
    Metabolism; 1985 May; 34(5):465-73. PubMed ID: 3887103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia.
    Rocić B; Breyer D; Granić M; Milutinović S
    Horm Metab Res; 1991 Oct; 23(10):490-4. PubMed ID: 1761280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
    Ibels SL; Reardon MF; Nestel PJ
    J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.